Several studies have documented dysregulated expression of LSM1 in various cancer types, including lung cancer [7], prostate cancer [8], and breast cancer [9], indicating its potential as an oncogenic driver promoting tumor cell proliferation, invasion, and metastasis in multiple malignancies [10]. The gene discussed is LSM1; the disease is lung cancer.